MYCIO Wealth Partners’s Collegium Pharmaceutical COLL Stock Holding History

MYCIO Wealth Partners’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,000	Closed	-$281K	–	279
2018 Q1	$281K	Hold	11,000	–	–	0.03%	191
2017 Q4	$203K	Hold	11,000	–	–	0.02%	232
2017 Q3	$115K	Hold	11,000	–	–	0.01%	239
2017 Q2	$138K	Sell	11,000 -6,000	-35%	-$59.3K	0.02%	226
2017 Q1	$171K	Hold	17,000	–	–	0.02%	239
2016 Q4	$265K	Hold	17,000	–	–	0.04%	174
2016 Q3	$327K	Hold	17,000	–	–	0.05%	126
2016 Q2	$201K	Sell	17,000 -15,901	-48%	-$263K	0.03%	169
2016 Q1	$597K	Buy	32,901 +21,901	+199%	+$398K	0.11%	86
2015 Q4	$303K	Buy	11,000 +6,000	+120%	+$126K	0.05%	117
2015 Q3	$111K	Buy	+5,000	New	+$90.4K	0.02%	190

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

MYCIO Wealth Partners's COLL Position: Q2 2018 in Review

MYCIO Wealth Partners sold out of Collegium Pharmaceutical (COLL) in Q2 2018, closing a stake of 11,000 shares — an estimated $281K sold.

MYCIO Wealth Partners first reported a position in COLL in Q3 2015 and held it in 11 quarters. The position peaked at $597K in Q1 2016. 133 funds tracked by Wall St. Rank hold COLL as of Q2 2018.

MYCIO Wealth Partners reported no remaining Collegium Pharmaceutical position as of Q2 2018 after selling out during the quarter.
MYCIO Wealth Partners sold 11,000 Collegium Pharmaceutical shares in Q2 2018, an estimated $281K.
MYCIO Wealth Partners first reported a position in Collegium Pharmaceutical in Q3 2015 and held it in 11 quarters.
MYCIO Wealth Partners's Collegium Pharmaceutical position peaked at $597K in Q1 2016.
133 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2018.

Based on MYCIO Wealth Partners's 13F filing for Q2 2018, filed 19 Jul 2018.